Announcement on the Change of Quality Control Reviewer
Filed with SSE · · 3 pages · Chinese
Harbin Pharmaceutical Group Co., Ltd. on 6ix
Earlier from Harbin Pharmaceutical
- Announcement on the Change of Signatory Certified Public Accountant and Quality Control Reviewer
- Announcement on Resolutions of the 22nd Meeting of the 10th Board of Directors
- Announcement on Reduction of Shares Held by the Company in Some of Holding Subsidiaries
- Announcement on Resolutions of the 20th Meeting of the 10th Board of Directors
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
Later from Harbin Pharmaceutical
- Announcement on Estimated Daily Related Party Transactions in 2026
- Announcement on Subsidiary Obtaining Drug Registration Certificate
- Announcement on Affiliated Enterprise Obtaining Approval for Marketing of Chemical APIs
- Announcement on Subsidiary's Drug Passing the Consistency Evaluation for Generic Drugs
- Announcement on Resolutions of the 24th Meeting of the 10th Board of Directors
Follow Harbin Pharmaceutical into a list and get an email when it puts out news.
Follow Harbin Pharmaceutical